Raphael Pharmaceutical (RAPH) Profit After Tax (2020 - 2024)
Raphael Pharmaceutical (RAPH) posted Profit After Tax of -$395000.0 for Q4 2024, down 21.17% sequentially from -$326000.0 in Q3 2024, and down 423.77% YoY from $122000.0 in Q1 2024.
Raphael Pharmaceutical (RAPH) Profit After Tax (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical has reported Profit After Tax for 5 years, with the latest figure at -$395000.0 in Q4 2024.
- Quarterly Profit After Tax fell 423.77% year-over-year to -$395000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.5 million (down 18.3% YoY) and the FY2025 annual result came in at -$1.3 million, up 15.8% from the prior year.
- Profit After Tax retreated to -$395000.0 in Q4 2024 per RAPH's latest filing, from -$326000.0 in the prior quarter.
- Over five years, Profit After Tax peaked at $122000.0 in Q4 2023 and troughed at -$1.4 million in Q3 2022.
- A 5-year average of -$471529.4 and a median of -$395000.0 in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 111.06% in 2023, then plunged 423.77% in 2024.
- Over 5 years, Profit After Tax stood at -$230000.0 in 2020, then slumped by 146.52% to -$567000.0 in 2021, then sank by 94.53% to -$1.1 million in 2022, then soared by 111.06% to $122000.0 in 2023, then slumped by 423.77% to -$395000.0 in 2024.
- According to Business Quant data, Profit After Tax over the past three periods registered -$395000.0, -$326000.0, and -$248000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -223,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -395,000.00 |
| Sep 30, 2024 | -326,000.00 |
| Jun 30, 2024 | -248,000.00 |
| Mar 31, 2024 | -550,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Sep 30, 2023 | -725,000.00 |
| Jun 30, 2023 | -417,000.00 |
| Mar 31, 2023 | -264,000.00 |
| Dec 31, 2022 | -1.10 Mn |
| Sep 30, 2022 | -1.44 Mn |
| Jun 30, 2022 | -627,000.00 |
| Mar 31, 2022 | -185,000.00 |
| Dec 31, 2021 | -567,000.00 |
| Sep 30, 2021 | -416,000.00 |
| Jun 30, 2021 | -387,000.00 |
| Mar 31, 2021 | -255,000.00 |
| Dec 31, 2020 | -230,000.00 |